KR101782858B1 - Toothpaste composition comprising of medicinal plants - Google Patents
Toothpaste composition comprising of medicinal plants Download PDFInfo
- Publication number
- KR101782858B1 KR101782858B1 KR1020160033805A KR20160033805A KR101782858B1 KR 101782858 B1 KR101782858 B1 KR 101782858B1 KR 1020160033805 A KR1020160033805 A KR 1020160033805A KR 20160033805 A KR20160033805 A KR 20160033805A KR 101782858 B1 KR101782858 B1 KR 101782858B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- present
- dentifrice composition
- extracts
- octopus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 105
- 239000000606 toothpaste Substances 0.000 title claims description 29
- 229940034610 toothpaste Drugs 0.000 title claims description 28
- 239000000284 extract Substances 0.000 claims abstract description 173
- 239000000551 dentifrice Substances 0.000 claims abstract description 51
- 235000013527 bean curd Nutrition 0.000 claims abstract description 33
- 241000238413 Octopus Species 0.000 claims abstract description 27
- 229940119485 safflower extract Drugs 0.000 claims abstract description 26
- 241000194019 Streptococcus mutans Species 0.000 claims abstract description 23
- 206010006326 Breath odour Diseases 0.000 claims abstract description 22
- 241000590002 Helicobacter pylori Species 0.000 claims abstract description 18
- 229940037467 helicobacter pylori Drugs 0.000 claims abstract description 18
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims abstract description 15
- 241000605862 Porphyromonas gingivalis Species 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 235000021374 legumes Nutrition 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 21
- 241000894006 Bacteria Species 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 16
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 15
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 15
- 239000011425 bamboo Substances 0.000 claims description 15
- -1 safflower extract Substances 0.000 claims description 15
- 239000004088 foaming agent Substances 0.000 claims description 14
- 239000000796 flavoring agent Substances 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- 239000002562 thickening agent Substances 0.000 claims description 10
- 235000003599 food sweetener Nutrition 0.000 claims description 9
- 239000003765 sweetening agent Substances 0.000 claims description 9
- 239000000080 wetting agent Substances 0.000 claims description 9
- 235000013355 food flavoring agent Nutrition 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 235000009075 Cucumis anguria Nutrition 0.000 claims description 3
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 3
- 231100000676 disease causative agent Toxicity 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000002362 mulch Substances 0.000 claims description 2
- 244000082204 Phyllostachys viridis Species 0.000 claims 3
- 240000008067 Cucumis sativus Species 0.000 claims 1
- 240000004658 Medicago sativa Species 0.000 claims 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims 1
- 229920002684 Sepharose Polymers 0.000 claims 1
- 240000006394 Sorghum bicolor Species 0.000 claims 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims 1
- 239000000419 plant extract Substances 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 21
- 240000006439 Aspergillus oryzae Species 0.000 abstract description 17
- 235000002247 Aspergillus oryzae Nutrition 0.000 abstract description 17
- 241000196324 Embryophyta Species 0.000 abstract description 15
- 208000028169 periodontal disease Diseases 0.000 abstract description 14
- 238000002360 preparation method Methods 0.000 abstract description 8
- 244000052769 pathogen Species 0.000 abstract description 7
- 230000002265 prevention Effects 0.000 abstract description 5
- 244000052616 bacterial pathogen Species 0.000 abstract description 4
- 241001092365 Penthorum Species 0.000 abstract description 2
- 235000018927 edible plant Nutrition 0.000 abstract description 2
- 230000006872 improvement Effects 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 231100000956 nontoxicity Toxicity 0.000 abstract description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 19
- 230000000845 anti-microbial effect Effects 0.000 description 17
- 208000024693 gingival disease Diseases 0.000 description 17
- 235000002639 sodium chloride Nutrition 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 235000010469 Glycine max Nutrition 0.000 description 14
- 244000068988 Glycine max Species 0.000 description 14
- 238000000605 extraction Methods 0.000 description 13
- 241001330002 Bambuseae Species 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 210000000214 mouth Anatomy 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 11
- 239000002904 solvent Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000000377 silicon dioxide Substances 0.000 description 8
- 235000012239 silicon dioxide Nutrition 0.000 description 8
- 239000006188 syrup Substances 0.000 description 8
- 235000020357 syrup Nutrition 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 235000020712 soy bean extract Nutrition 0.000 description 7
- 241000244938 Penthorum chinense Species 0.000 description 6
- 241000269821 Scombridae Species 0.000 description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 235000020640 mackerel Nutrition 0.000 description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 6
- 201000001245 periodontitis Diseases 0.000 description 6
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 6
- 239000000811 xylitol Substances 0.000 description 6
- 235000010447 xylitol Nutrition 0.000 description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 6
- 229960002675 xylitol Drugs 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- 241000605894 Porphyromonas Species 0.000 description 5
- 241000208422 Rhododendron Species 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000007505 plaque formation Effects 0.000 description 5
- 229960002920 sorbitol Drugs 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010018276 Gingival bleeding Diseases 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 208000002925 dental caries Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 108700004121 sarkosyl Proteins 0.000 description 4
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 4
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 235000003826 Artemisia Nutrition 0.000 description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000255749 Coccinellidae Species 0.000 description 3
- 241000238557 Decapoda Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 241000234280 Liliaceae Species 0.000 description 3
- 241000218657 Picea Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 244000030166 artemisia Species 0.000 description 3
- 235000009052 artemisia Nutrition 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 210000003298 dental enamel Anatomy 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 208000011759 gum bleeding Diseases 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000003239 periodontal effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000512259 Ascophyllum nodosum Species 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 240000001251 Cucumis anguria Species 0.000 description 2
- 208000006558 Dental Calculus Diseases 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010017711 Gangrene Diseases 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- 101710154606 Hemagglutinin Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- 208000025157 Oral disease Diseases 0.000 description 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 101710176177 Protein A56 Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 244000207667 Rumex vesicarius Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000004195 gingiva Anatomy 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000000185 hemagglutinin Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229940030961 sorghum extract Drugs 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- NFHFNBFYZIJLKZ-UHFFFAOYSA-N Asarinin Natural products CC1(OCC2C1COC2c3ccc4OCOc4c3)c5ccc6OCOc6c5 NFHFNBFYZIJLKZ-UHFFFAOYSA-N 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- PSMFFFUWSMZAPB-UHFFFAOYSA-N Eukalyptol Natural products C1CC2CCC1(C)COCC2(C)C PSMFFFUWSMZAPB-UHFFFAOYSA-N 0.000 description 1
- 241000434018 Euphorbia pekinensis Species 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 241001315191 Gladiata Species 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000064622 Physalis edulis Species 0.000 description 1
- 235000009230 Physalis pubescens Nutrition 0.000 description 1
- 240000001558 Physalis viscosa Species 0.000 description 1
- 235000002491 Physalis viscosa Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 235000021501 Rumex crispus Nutrition 0.000 description 1
- 235000015422 Rumex crispus ssp. crispus Nutrition 0.000 description 1
- 235000015426 Rumex crispus ssp. fauriei Nutrition 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 239000004383 Steviol glycoside Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229930185278 anthraglycoside Natural products 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Chemical class CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- IJIHXVOFOSQRHF-UHFFFAOYSA-N bis(2,4,5-trimethoxyphenyl)methanone Chemical compound C1=C(OC)C(OC)=CC(OC)=C1C(=O)C1=CC(OC)=C(OC)C=C1OC IJIHXVOFOSQRHF-UHFFFAOYSA-N 0.000 description 1
- 238000002815 broth microdilution Methods 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 210000004513 dentition Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical class C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- WPHGSKGZRAQSGP-UHFFFAOYSA-N methylenecyclohexane Natural products C1CCCC2CC21 WPHGSKGZRAQSGP-UHFFFAOYSA-N 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 210000002379 periodontal ligament Anatomy 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 235000019411 steviol glycoside Nutrition 0.000 description 1
- 229930182488 steviol glycoside Natural products 0.000 description 1
- 150000008144 steviol glycosides Chemical class 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000036346 tooth eruption Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 약용식물 추출물을 함유하는 치약 조성물 및 그 제조방법에 관한 것으로, 더욱 자세하게는 유효성분으로서 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 포함하여 치주질환 치료 효과 및 구취 제거 효과를 갖는 치약 조성물에 관한 것이다. 본 발명에 따른 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 특정 배합비로 포함하는 치약 조성물은 충치유발 원인균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans) 및 풍치 유발 원인균인 포르피로모나스 긴기발리스(porphyromonas gingivalis) 병원균에 대한 강한 항균 활성을 보이며, 특히 상기 3종의 추출물에 낙지다리(Penthorum chinense Pursh) 추출물을 더 첨가하여 제조한 치약 조성물의 경우 헬리코박터 파일로리(Helicobacter pylori) 병원균에 대한 항균 활성을 갖는바, 치주질환 개선(또는 예방)과 구취제거 효과를 갖는 새로운 기능성 치약 조성물로서 유용하게 사용될 수 있다. 특히 작두콩, 소리쟁이, 족두리풀은 식용 가능한 식물이며, 낙지다리풀도 독성이 없는 식물로서 이로부터 유래한 추출물을 포함하는 본 발명의 치약 조성물은 장기간 사용에도 안전한 이점을 가진다.The present invention relates to a dentifrice composition containing a medicinal plant extract and a preparation method thereof, and more particularly to a dentifrice composition having an effect of treating periodontal disease and removing bad breath including an extract of a soybean curd extract, a safflower extract and a safflower extract as active ingredients . The dentifrice compositions containing the extracts of the extracts of Aspergillus oryzae according to the present invention in a specific blending ratio can be used for a variety of dentifrice compositions such as Streptococcus mutans causative of cavities and porphyromonas gingivalis , It showed a strong antibacterial activity against pathogenic bacteria, especially octopus legs (Penthorum the extracts of the three kinds of chinense The dentifrice composition prepared by adding the Pursh extract has antibacterial activity against Helicobacter pylori pathogens and can be effectively used as a new functional dentifrice composition having periodontal disease improvement (or prevention) and bad breath removal effect have. The dentifrice composition of the present invention, which contains extracts derived therefrom, is a plant which is an edible plant, and which has no toxicity to octopus legumes, and has safety advantages even for long-term use.
Description
본 발명은 약용식물 추출물을 함유하는 치약 조성물 및 그 제조방법에 관한 것으로, 더욱 자세하게는 유효성분으로서 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 포함하여 치주질환 치료 효과 및 구취 제거 효과를 갖는 치약 조성물에 관한 것이다.The present invention relates to a dentifrice composition containing a medicinal plant extract and a preparation method thereof, and more particularly to a dentifrice composition having an effect of treating periodontal disease and removing bad breath including an extract of a soybean curd extract, a safflower extract and a safflower extract as active ingredients .
일반적으로 인체에 있어서의 구강은, 앞쪽 입술부터 뒤쪽 구협(口峽)까지의 인두에 연결되는 입안의 공간으로서 저작, 구강 소화, 미각 등 음식물에 관계되는 여러 가지 기능 이외에 어음(語音)의 구성을 비롯하여 침샘의 내분비 작용이나 호흡 등에도 관여한다. 즉, 음식물 섭취를 통하여 얻어지는 모든 영양소와 대기 중의 병원균이 인체내로 침입되는 1차 관문으로서, 저작기능과 발성기능, 외관상의 심미적 기능에 직접 관련된 치아와 그것을 지탱해주는 잇몸, 맛을 느끼고 치아와 함께 발성기능에 관여하는 혀와 같은 기관이 상호 유기적으로 연결되어 인체의 건강을 책임지는 중요한 기관인 것이다. In general, the oral cavity in the human body is a space in the mouth which is connected to the pharynx from the front lip to the rear mouth (mouth 峽). In addition to various functions related to food such as mastication, oral digestion and taste, As well as the endocrine action of salivary glands and respiration. In other words, it is the first gateway that all nutrients and atmospheric pathogens obtained through ingestion of food are invaded into the human body. It is used as a gateway to the function of chewing function and vocalization function, a tooth directly related to the aesthetic function of appearance, and gums supporting it, It is an important organ responsible for the health of the human body, such as the tongue, which is involved in function, is linked organically.
구강 내에 존재하는 치아의 치주 조직은 크게 백악질, 치은(잇몸),치주인대, 치조골로 나누어 구분하고 있다. 이러한 치주 조직과 치은을 보호하기 위해서는 식사 후 칫솔질이 매우 중요하며, 이때 치약이나 가글제를 사용하여 음식물의 산, 음식물 찌꺼기, 유해미생물을 제거하여 충치 및 치태 발생과 유해 미생물에 의한 악취를 예방하고 있다. 그러나 치태 발생의 경우 가글제만으로는 치태 발생을 막기 어려워 반드시 칫솔질이 필요하다. Periodontal tissues in the oral cavity are divided into cementum, gingiva (gum), periodontal ligament, and alveolar bone. To protect such periodontal tissues and gingiva, brushing after eating is very important. In this case, toothpaste and gaggle are used to remove acid, food waste, and harmful microorganisms in the food to prevent tooth decay and stomach upset and odor caused by harmful microorganisms . However, in the case of plaque occurrence, it is hard to prevent the occurrence of plaque by only gagulje, so brushing is always necessary.
치태란 세균, 세균의 대사물질 또는 숙주 생물의 타액으로 이루어진 아주 얇고 투명한 막으로서, 치아 표면에 형성되는 무색의 세균막을 말한다. 치태가 형성되면 그 내부의 세균은 숙주 생물이 섭취하는 음식물 등을 통해 공급되는 당분을 이용하여 기하급수적으로 번식한다. 치태 속에 있는 세균은 잇몸을 상하게 하는 독소와 유리산소를 만들어 치아를 둘러싸고 있는 조직을 파괴한다. 이렇게 되면 잇몸에 염증이 생겨, 잇몸이 빨갛게 되면서 쉽게 붓고 자주 피가 나게 된다. 또한, 잇몸과 치아사이 (치은열구) 에는 그 틈이 벌어져 치주낭이라는 작은 주머니가 생길 수 있는데, 여기에 치태가 쌓이게 되면 세균이 치근면을 따라 내려가 치아를 지탱하는 뼈를 파괴하여 심한 경우에는 치아를 상실하게 된다.A stigma is a very thin and transparent film consisting of bacteria, metabolites of bacteria or saliva of a living organism, which is a colorless bacterial film formed on the tooth surface. When the plaque is formed, the bacteria inside it multiply exponentially using the sugar that is supplied through the food consumed by the host organism. Bacteria in the dentition create toxins and free oxygen that breaks the gums, destroying the tissue surrounding the teeth. This causes irritation of the gums, redness of the gums, easy pouring and frequent bleeding. In addition, gaps between the gums and the teeth (gingival fissures) can open up a small pocket called a periodontal pouch. When the tooth builds up, the germs descend along the root surface to destroy the bone supporting the tooth, It is lost.
또한, 제거되지 않은 치태가 타액과 치은열구 내의 칼슘 또는 인 등의 무기질과 함께 침착되어 치석이 만들어진다. 치석은 플라그(plaque)라고도 불리며 부식성 산독성 물질로써 눈에 잘 보이지 않는 투명한 막으로 구강질환의 가장 직접적인 원인이 되는 물질이다. 주로 치아 표면에서 산을 발생시킴으로써 치아의 딱딱한 부분인 법랑질을 파괴하여 치석과 발치에 이르게 하고 잇몸질환을 유발한다. 특히 스트렙토코코스 뮤탄스(Streptococcus mutans)와 같은 구강 내 세균은 음식물의 발효를 증가시켜 입안의 pH를 중성에서 약산성으로 떨어뜨려 구취, 프라그 형성 및 치주질환의 주된 원인이다.In addition, unremoved plaque is deposited with saliva and minerals such as calcium or phosphorus in the gingival fissure to create tartar. Calcite is also known as plaque and is a corrosive acid toxic substance that is an invisible transparent membrane and is the most direct cause of oral disease. Generating acid on the surface of teeth usually destroys the enamel, which is a hard part of the tooth, leading to calculus and extraction, and causing gum disease. In particular, oral bacteria such as Streptococcus mutans increase the fermentation of food to lower the pH of the mouth from neutral to slightly acidic, leading to halitosis, plaque formation and periodontal disease.
프라그 형성을 방지하기 위한 노력으로 생약제나 화합물을 사용한 치약 조성물 연구가 활발히 진행되고 있다. 그러나 종래의 치약은 프라그 제거를 위해 강한 연마제를 사용하고 있으나 이가 약한 노인이나 이가 시린 증상을 갖고 있는 사람들에게는 강한 연마제가 포함된 치약 사용이 바람직하지 않으며, 각종 잇몸질환과 치주질환을 예방하고 발생된 질환의 감소와 치유 효과를 기대하는 것이 실질적으로 어려운 실정이다.In an effort to prevent the formation of plaque, studies on dentifrice compositions using herbicides or compounds have been actively conducted. However, the conventional toothpaste uses a strong abrasive for removing the plaque, but it is not preferable to use a toothbrush containing a strong abrasive for those who have weak elderly people or those suffering from itigicin, and it is necessary to prevent various gum disease and periodontal disease, It is practically difficult to expect reduction of disease and healing effect.
따라서 치태 형성의 원인균에 해당하는 스트렙토코코스 뮤탄스(Streptococcus mutans)의 생장 억제를 통한 프라그 형성을 방지하고 이와 더불어 구강 내 서식하면서 냄새를 유발하는 세균 억제를 통해 치태의 형성을 막아 치아를 보호하는 근본적인 해결책이 요구되어진다.Therefore, prevention of plaque formation by inhibiting the growth of Streptococcus mutans , which is the causative organism of plaque formation, and the prevention of formation of plaque by inhibiting bacteria that cause odor and living in the oral cavity, A solution is required.
이에, 본 발명자는 충치유발 원인균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans), 풍치 유발 원인균인 포르피로모나스 긴기발리스(porphyromonas gingivalis) 및 구취 유발 원인균인 헬리코박터 파일로리(Helicobacter pylori) 병원균에 대한 우수한 항균성을 갖는 천연 소재로서 치약에 적용할 수 있는 약용식물을 찾고자 연구한 결과, 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 특정 배합비로 포함하는 치약 조성물이 스트렙토코쿠스 뮤탄스 및 포르피로모나스 긴기발리스 병원균에 대한 강한 항균 활성을 보이며, 특히 상기 3종의 추출물에 낙지다리(Penthorum chinense Pursh) 추출물을 더 첨가하여 제조한 치약 조성물의 경우 헬리코박터 파일로리균에 대한 항균 활성도 갖는 것을 확인함으로써 본 발명을 완성하였다.Thus, the present inventors have superior antimicrobial activity of the cavity causing pathogen is Streptococcus mutans (Streptococcus mutans), taste causing organisms in Fort fatigue Pseudomonas long eccentricity less (porphyromonas gingivalis) and halitosis causing pathogen is Helicobacter pylori (Helicobacter pylori) pathogens As a result of searching for a medicinal plant which can be applied to toothpaste as a natural material having a specific composition ratio, a toothpaste composition containing a combination of a soybean curd extract, a safflower extract and a bamboo shoot extract at a specific blending ratio is added to Streptococcus mutans and Porphyromonas gingivalis pathogens ( Penthorum chinense) was applied to the three kinds of extracts, Pursh ) extract of the present invention has antibacterial activity against Helicobacter pylori. The present invention has been completed based on this finding.
따라서 본 발명의 목적은 천연 약용식물 추출물을 이용하여 장기간 사용에도 인체에 안정하면서 충치유발 원인균에 대한 항균 활성이 우수한 치약 조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a dentifrice composition that is stable to human body and has excellent antimicrobial activity against bacteria causing cavities even when used for a long time by using a natural medicinal plant extract.
본 발명의 또 다른 목적은 천연 약용식물 추출물을 이용하여 장기간 사용하여도 인체에 안전하면서 충치유발 원인균에 대한 항균 활성이 우수한 치약 조성물의 제조방법을 제공하는 것이다.Another object of the present invention is to provide a method for manufacturing a dentifrice composition which is safe for human body and is excellent in antimicrobial activity against bacteria causing cavities even when it is used for a long time by using a natural medicinal plant extract.
상기와 같은 본 발명의 목적을 달성하기 위해서, In order to achieve the above-mentioned object of the present invention,
본 발명은 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 유효성분으로 포함하는 치약 조성물을 제공한다.The present invention provides a dentifrice composition comprising a soybean curd extract, a safflower extract, and a safflower extract as an active ingredient.
본 발명의 일실시예에 있어서, 상기 추출물은 열수추출물일 수 있다.In one embodiment of the present invention, the extract may be a hot-water extract.
본 발명의 일실시예에 있어서, 상기 조성물은 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 1-5 : 1-5 : 1의 중량비로 포함할 수 있다.In one embodiment of the present invention, the composition may include a soybean curd extract, a safflower extract and a safflower extract at a weight ratio of 1-5: 1-5: 1.
본 발명의 일실시예에 있어서, 상기 조성물은 충치유발 원인균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans) 및 풍치 유발 원인균인 포르피로모나스 긴기발리스(porphyromonas gingivalis)에 대한 항균활성을 가질 수 있다.In one embodiment of the present invention, the composition may have antimicrobial activity against Streptococcus mutans , a causative organism causing cavities, and Porphyromonas gingivalis , a causative agent for aquatic plants .
본 발명의 일실시예에 있어서, 상기 조성물은 낙지다리(Penthorum chinense Pursh) 추출물을 더 포함할 수 있다.In one embodiment of the present invention, the composition comprises an octopus leg ( Penthorum chinense Pursh ) extract.
본 발명의 일실시예에 있어서, 상기 치약 조성물은 액상, 페이스트 또는 투명 겔 타입의 제형일 수 있다.In one embodiment of the present invention, the dentifrice composition may be in the form of a liquid, paste, or transparent gel type.
또한, 본 발명은 a) 작두콩, 소리쟁이, 족두리풀 각각에 중량 대비 5-10배의 물을 첨가하여 50-60℃ 온도에서 끊여 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 1차 수득하고, 건더기에 다시 물을 처음 용량으로 첨가하여 50-60℃ 온도에서 7-8시간 끊여 처음 용액양의 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 2차 수득한 다음, 이렇게 수득한 1차 추출액과 2차 추출액을 합하여 작두콩 추출물, 소리쟁이 추출물, 족두리풀 추출물 각각을 제조하는 단계; b) 상기 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물 3종을 혼합하는 단계; 및 c) 상기 혼합물에 천일염, 습윤제 및 감미제를 첨가하여 용해시킨 후 증점제, 연마제 및 기포제를 첨가하여 혼합하고 마지막으로 착향제를 첨가하는 단계를 포함하는 치약 조성물 제조방법을 제공한다.In addition, the present invention provides a method for producing a soybean curd, comprising the steps of: a) adding 5 to 10 times by weight of water to each of soybean curd, soybean curd, and bamboo shoots at a temperature of 50 to 60 DEG C to obtain a first- , Water was added to the vat in the first volume again, and the vial was cut at a temperature of 50-60 ° C for 7-8 hours to obtain a second volume of the extract except for the vat when the volume became one-third of the initial amount of the solution. Preparing an extract of the soybean curd extract, the extract of Aspergillus oryzae, and the extract of Aspergillus oryzae, respectively, by combining the extract and the secondary extract; b) mixing the soybean curd extract, the safflower extract, and the shoemaker extract; And c) adding a salt, a wetting agent and a sweetening agent to the mixture to dissolve the mixture, adding a thickener, an abrasive, and a foaming agent to the mixture, and finally adding a flavoring agent.
본 발명에 따른 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 특정 배합비로 포함하는 치약 조성물은 충치유발 원인균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans) 및 풍치 유발 원인균인 포르피로모나스 긴기발리스(porphyromonas gingivalis) 병원균에 대한 강한 항균 활성을 보이며, 특히 상기 3종의 추출물에 낙지다리(Penthorum chinense Pursh) 추출물을 더 첨가하여 제조한 치약 조성물의 경우 헬리코박터 파일로리(Helicobacter pylori) 병원균에 대한 항균 활성을 갖는바, 치주질환 개선(또는 예방)과 구취제거 효과를 갖는 새로운 기능성 치약 조성물로서 유용하게 사용될 수 있다. 특히 작두콩, 소리쟁이, 족두리풀은 식용 가능한 식물이며, 낙지다리풀도 독성이 없는 식물로서 이로부터 유래한 추출물을 포함하는 본 발명의 치약 조성물은 장기간 사용에도 안전한 이점을 가진다.The dentifrice compositions containing the extracts of the extracts of Aspergillus oryzae according to the present invention in a specific blending ratio can be used for a variety of dentifrice compositions such as Streptococcus mutans causative of cavities and porphyromonas gingivalis , It showed a strong antibacterial activity against pathogenic bacteria, especially octopus legs (Penthorum the extracts of the three kinds of chinense The dentifrice composition prepared by adding the Pursh extract has antibacterial activity against Helicobacter pylori pathogens and can be effectively used as a new functional dentifrice composition having periodontal disease improvement (or prevention) and bad breath removal effect have. The dentifrice composition of the present invention, which contains extracts derived therefrom, is a plant which is an edible plant, and which has no toxicity to octopus legumes, and has safety advantages even for long-term use.
도 1은 본 발명의 작두콩 추출물(작두콩 농축액)을 나타낸 사진이다.
도 2는 본 발명의 족두리풀 추출물(족두리풀 농축액)을 나타낸 사진이다.
도 3은 본 발명의 소리쟁이 추출물(소리쟁이 농축액)을 나타낸 사진이다.
도 4는 본 발명의 치약 조성물을 나타낸 사진이다.Fig. 1 is a photograph showing the soybean extract of the present invention (soybean concentrate).
FIG. 2 is a photograph showing the extract of Liliaceae (Liliaceae) concentrate of the present invention.
Fig. 3 is a photograph showing the spear extract (spruce concentrate) of the present invention.
4 is a photograph showing the dentifrice composition of the present invention.
본 발명은 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 유효성분으로 포함하는 치약 조성물을 제공함에 그 특징이 있다.The present invention is characterized by providing a dentifrice composition comprising an extract of the extracts of Aspergillus, Aspergillus oryzae as an active ingredient.
본 명세서에서 언급하는 ‘작두콩’은 학명이 Canavalia gladiata DC이며, 고려시대 왕실에서만 약재나 식품으로 사용되어온 왕실작물이며 조선시대 이후 고려말살정책으로 인하여 재배가 금지되어온 토종 전통식물이다. 작두콩은 열매가 활 모양으로 구부러진 꼬투리여서 그 모양이 작두같다 하여 작두콩 또는 도두라고 일컬어진다. 작두콩의 형태 및 특징은 한해살이 풀이며 잎은 세 개의 긴 닭알 모양 쪽잎으로 된 겹잎이며 3중겹침 형태를 지닌다. 연한 붉은색 또는 가지색의 꽃이 피고 씨의 배꼽길이는 씨길이의 절반이다. 생식질은 흰색꽃의 흰색립, 흰색꽃의 적색립, 적색꽃의 적색립으로 3종류의 재배종이 존재하며 한발, 강산성, 사질토양, 그늘진곳 등에 저항성이 큰 작물이다. 작두콩의 분포는 열대아시아, 아프리카, 인도지방에 널리 분포하고 해발 1000m이내에서 주로 재배되며, 동남아시아 및 우리나라에서도 재배되는 작물이다. 작두콩의 주요성분은 씨에는 우레아제, 혈구응집소, 카나바린 및 단백질, 기름등이 존재하며 혈구응집소는 Concanavalin A등의 여러 가지 글로불린으로 되어있다. 이 성분은 종양세포에 대한 특수 작용이 있는 것으로 알려져 있다. 이외에 글루코시다제, 아르기나제등이 있으며 다른 콩과 작물에 비하여 비타민 B군, 비타민 C, 나이아신이 3∼5배 가량 더 많이 존재한다.As used herein, the term " soybean & quot ; gladiata DC, a royal family crop that has been used only as a medicinal plant and food in the royal family of the Koryo Dynasty, and is a native plant that has been banned for cultivation due to the Koryo era. Soy beans are called pods or doodles because their shape is the same as they are bent pods. The shape and characteristics of soybean is annual plant, and the leaf is a compound leaf composed of three long chicken - egg - shaped leaflets and has a triple - lapped form. A light red or colored flower blooms and the length of the belly of the seed is half the length of the seed. There are three kinds of cultivars with white lips of white flowers, red lips of white flowers, and red lips of red flowers. It is a crop with high resistance to one foot, strong acidity, sandy soil and shady places. The distribution of soybean is widely distributed in tropical Asia, Africa, and India and is mainly cultivated within 1000m above sea level, and cultivated in Southeast Asia and Korea. The major constituents of soybean are urea, hemagglutinin, cannabarin, protein, and oil, and hemagglutinin is composed of various globulins such as Concanavalin A. This component is known to have a specific action on tumor cells. In addition, there are glucosidase, arginase, and vitamin B group, vitamin C, niacin is 3 to 5 times more than other soybean and crops.
본 명세서에서 언급하는 ‘소리쟁이’는 학명이 Rumex crispus L.이며 여러 해살이 풀로,양제엽, 송구지, 야당귀 등으로 불리며 전국의 들판과 산비탈의 습한 곳에서 흔하게 자란다.땅속에 비대한 뿌리줄기를 가지고 있으며, 굵은 줄기는 곧게 서서 30-80cm 정도로 자라는데, 세로 줄이 많으며 녹색바탕에 자주빛이 돈다. 어린 잎이 자라나올 무렵에는 키가 작고 나지막해 보인다. 봄에 어린 순을 나물로 먹고 뿌리는 약으로 쓴다. 이와 같은 소루쟁이에는 아스코르빈산, 크리소파놀, 에모딘, 안트라키논 유도체, 싱아산칼슘, 정유, 옥시메탈 안트로키논, 크리소판산, 안트라글리코시드 등이 있다."Curly dock" referred to herein is the scientific name Rumex crispus L. It is called Ladybird, Ladybird, Songguji, Opposite Ear, etc. It grows commonly in the wet areas of the fields and mountain slopes of the country. It has bloomed roots in the ground, and the coarse stems grow up to 30-80cm There are many vertical lines, and the backlight turns on the green background. By the time the young leaves grow up, they look tall and tiny. In spring, young seeds are eaten as herbs and rooted as medicine. Examples of such molluscs include ascorbic acid, crysopanol, emodin, anthraquinone derivatives, calcium monacalcium, essential oils, oxymetalanthroquinone, chrysopanic acid, anthraglycoside and the like.
본 명세서에서 언급하는 ‘족두리풀’은 학명이 Asarum sieboldii이며 여러해 살이풀로 세신, 족두리, 민족두리풀로 불리우며, 불규칙한 마디가 많은 담갈색의 뿌리줄기가 옆으로 뻗어나가며 뿌리를 내린다. 뿌리에서 2개의 잎이 나와 마주보며 퍼진다. 족두리 모양의 잎이 닮아서 붙여진 이름으로 높이가 20cm 정도 자라며 매운 맛이 나는 뿌리는 마디가 많고 수염뿌리가 많이 나며 육질이다. 유효성분으로는 메틸유제놀(Methyleugenol), Asarylketone, 사프롤(Safrole), 1,8-시네올(1,8-cineol), 아사리닌(Asarinin), Eucavone 등이 함유되어 있다(동의한방 약초도감, p56-p57, 최수찬, 지식서관, 2015)."Jokduripul 'scientific names mentioned herein are the Asarum It is called sieboldii. It is called a perennial plant. It is called a tsukuri, a foxbush, and a rootstock with many irregular nodes spreads to the side, and its roots descend. Two leaves from the roots face each other and spread. It grows about 20cm in height with the name of the leaf which is similar to the stem-shaped leaf. The spicy root has a lot of nodes, a lot of beard roots and meat quality. The active ingredients include Methyleugenol, Asarylketone, Safrole, 1,8-cineol, Asarinin, Eucavone, etc. , p56-p57, Choi, Soon Chan, Knowledge Center, 2015).
본 발명자는 구강 내 유해 세균에 대한 우수한 항균성을 갖는 천연 소재로서 치약에 적용할 수 있는 약용식물을 찾고자 연구하였으며, 그 결과 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 특정 배합비로 포함하는 치약 조성물이 스트렙토코쿠스 뮤탄스 및 포르피로모나스 긴기발리스 병원균에 대한 강한 항균 활성을 보이는 것을 최초로 규명하였다.The present inventors have searched for a medicinal plant which can be applied to toothpaste as a natural material having excellent antimicrobial activity against harmful bacteria in the oral cavity. As a result, a toothpaste composition containing a soybean extract, a safflower extract and a safflower extract at a specific blending ratio, Coxs mutans and Porphyromonas gingivalis were identified for the first time.
그러므로 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 유효성분으로 포함하는 본 발명의 조성물은 치약 소재로서 유용하게 사용될 수 있다. Therefore, the composition of the present invention comprising the extracts of Aspergillus, Aspergillus oryzae as an active ingredient can be usefully used as a toothpaste material.
본 발명에 따른 추출물은 당업계에 공지된 추출 및 분리하는 방법을 사용하여 천연으로부터 추출 및 분리하여 수득한 것을 사용할 수 있으며, 본 발명에서 정의된‘추출물’은 적절한 용매를 이용하여 약용식물(작두콩, 소리쟁이, 족두리풀) 로부터 추출한 것이며, 예를 들어, 상기 약용식물의 조추출물, 극성용매 가용 추출물 또는 비극성용매 가용 추출물을 모두 포함한다. The extract according to the present invention can be obtained by extracting and isolating from nature using extraction and isolation methods known in the art, and the 'extract' as defined in the present invention can be obtained by using an appropriate solvent, For example, crude extract, polar solvent-soluble extract or non-polar solvent-soluble extract of the medicinal plant.
상기 작두콩, 소리쟁이 및 족두리풀로부터 추출물을 추출하기 위한 적절한 용매로는 약학적으로 허용되는 유기용매라면 어느 것을 사용해도 무방하며, 물 또는 유기용매를 사용할 수 있으며, 이에 제한되지는 않으나, 예를 들어, 정제수(물), 메탄올(methanol), 에탄올(ethanol), 프로판올(propanol), 이소프로판올(isopropanol), 부탄올(butanol) 등을 포함하는 탄소수 1 내지 4의 알코올, 아세톤(acetone), 에테르(ether), 벤젠(benzene), 클로로포름(chloroform), 에틸아세테이트(ethyl acetate), 메틸렌클로라이드(methylene chloride), 헥산(hexane) 및 시클로헥산(cyclohexane) 등의 각종 용매를 단독으로 혹은 혼합하여 사용할 수 있다. 바람직하게는 물을 사용하는 것이 좋다.As an appropriate solvent for extracting the extract from the soybean sprout, safflower, and shoemaker, any organic solvent that is pharmaceutically acceptable may be used, and water or an organic solvent may be used. For example, Alcohol having 1 to 4 carbon atoms, acetone, ether, or the like containing water, purified water, methanol, ethanol, propanol, isopropanol, butanol, Various solvents such as benzene, chloroform, ethyl acetate, methylene chloride, hexane and cyclohexane may be used alone or in combination. Preferably, water is used.
추출 방법으로는 열수추출법, 냉침추출법, 환류냉각추출법, 용매추출법, 수증기증류법, 초음파추출법, 용출법, 압착법 등의 방법 중 어느 하나를 선택하여 사용할 수 있다. 또한, 목적하는 추출물은 추가로 통상의 분획 공정을 수행할 수도 있으며, 통상의 정제 방법을 이용하여 정제될 수도 있다. 본 발명의 약용식물 추출물의 제조방법에는 제한이 없으며, 공지되어 있는 어떠한 방법도 이용될 수 있다.As the extraction method, any one of the methods such as hot water extraction method, cold extraction method, reflux cooling extraction method, solvent extraction method, steam distillation method, ultrasonic extraction method, elution method and compression method can be selected and used. In addition, the desired extract may be further subjected to a conventional fractionation process or may be purified using a conventional purification method. The method for producing the medicinal plant extract of the present invention is not limited, and any known method can be used.
예를 들면, 본 발명의 조성물에 포함되는 약용식물 추출물은 상기한 열수 추출 또는 용매 추출법으로 추출된 1차 추출물을, 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조할 수 있다. 또한 상기 1차 추출물을 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 박층 크로마토그래피(thin layer chromatography), 고성능 액체 크로마토그래피(high performance liquid chromatography) 등과 같은 다양한 크로마토그래피를 이용하여 추가로 정제된 분획을 얻을 수도 있다.For example, the medicinal plant extract contained in the composition of the present invention may be prepared into a powdery state by an additional process such as vacuum distillation, freeze-drying, or spray drying, have. Further, the primary extract can be further purified by using various chromatographies such as silica gel column chromatography, thin layer chromatography, high performance liquid chromatography and the like, You can get it.
따라서 본 발명에 있어서 약용식물 추출물은 추출, 분획 또는 정제의 각 단계에서 얻어지는 모든 추출액, 분획 및 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념이다.Therefore, the medicinal plant extract in the present invention is a concept including all of the extract, fraction and purified product obtained in each step of extraction, fractionation or purification, a diluted solution thereof, a concentrate or a dried product.
본 발명에서 세 가지 약제들(작두콩, 소리쟁이, 족두리풀)은 모두를 한꺼번에 넣고 추출할 수도 있고 각각 추출한 후 혼합하여 사용할 수도 있으나, 유효성분의 효율적 추출과, 약용식물의 혼합 추출 시 부성분의 추출을 최대한 억제하기 위하여 개별 추출 후 혼합 사용하는 것이 바람직하다.In the present invention, all of the three medicines (eg, soybean sprouts, shrubs, and shrubs) can be extracted at once, or they can be extracted and mixed. However, efficient extraction of the active ingredient and extraction of subcomponents during mixed extraction of medicinal plants It is preferable to use them separately and then mix them together.
본 발명의 일실시예에 따른 약용식물 추출물을 제조하는 방법을 조금 더 구체적으로 살펴보면 다음과 같다.The method for producing the medicinal plant extract according to one embodiment of the present invention will be described in more detail as follows.
작두콩, 소리쟁이, 족두리풀 각각에 중량 대비 5-10배의 물을 첨가하여 50-60℃ 온도에서 끊여 수용액 양이 1/3이 되었을 때 건더기를 제외한 추출액을 1차 수득하고, 건더기에 다시 물을 처음 용량으로 첨가한 후 50-60℃ 온도에서 수용액 양이 1/3이 될 때까지 끊여 작두리콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물 각각을 제조할 수 있다.5-10 times the weight of water was added to each of the soybean curd, shrubs and shrimp, and the mixture was cooled at a temperature of 50-60 ° C. When the amount of the aqueous solution became 1/3, the extract solution except the mulch was firstly obtained, After the addition at the initial dose, the extracts can be prepared at 50-60 ° C until the amount of aqueous solution is reduced to 1/3, respectively, to produce each of the extracts of Aspergillus oryzae, Aspergillus oryzae.
건조된 세 가지 약제들(작두콩, 소리쟁이, 족두리풀)은 모두를 한꺼번에 넣고 추출할 수도 있고 각각 추출한 후 혼합하여 사용할 수도 있으나 유효 성분의 효율적 추출과, 약용식물의 혼합 추출 시 부성분의 추출을 최대한 억제하기 위하여 개별 추출 후 혼합 사용법을 따랐다.It is possible to extract all three dried drugs (soybean sprout, spruce sprout, and spruce sprout) at once, but they can be extracted and mixed after they are separately extracted. However, efficient extraction of active ingredients and extraction of subcomponents during mixed extraction of medicinal plants are minimized To do this, individual extraction and mixing methods were followed.
본 발명의 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물 각각은 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대한 우수한 항균 활성을 가지며, 상기 약용식물 추출물을 특정 비율로 혼합하여 제조된 조성물의 경우 스트렙토코쿠스 뮤탄스와 더불어 포르피로모나스 긴기발리스(porphyromonas gingivalis)에 대한 강한 항균활성을 보인다.Each of the soybean curd extract, the safflower extract and the bamboo shoot extract of the present invention has an excellent antimicrobial activity against Streptococcus mutans . In the case of a composition prepared by mixing the medicinal plant extract at a specific ratio, (Porphyromonas gingivalis ), in addition to Pseudomonas sp .
본 발명의 일실시예에 있어서, 상기 조성물은 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 1-5 : 1-5 : 1의 중량비로 포함할 수 있으며, 바람직하게는 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 5 : 5 : 1의 중량비로 포함할 수 있다.In one embodiment of the present invention, the composition may contain the soybean curd extract, the safflower extract and the safflower extract at a weight ratio of 1-5: 1-5: 1, and preferably the soybean curd extract, the safflower extract, The extract may be contained in a weight ratio of 5: 5: 1.
본 명세서에서 언급하는 ‘스트렙토코쿠스 뮤탄스(Streptococcus mutans)’는 정상인의 구강 내에 존재하는 박테리아 종으로, 에나멜 손상의 초기 단계와 관련이 있으며, 충치의 주요 원인균이다. 당을 분해하여, 불용성인 덱스트란을 합성하며, 덱스트란은 뮤턴스를 비롯한 구강세균을 응집하여, 프라그를 형성하고, 프라그의 대사물질(산)에 의해 에나멜질 탈회, 충치를 발생시킨다. Streptococcus mutans referred to herein is a bacterial species present in the oral cavity of a normal person and is associated with an early stage of enamel damage and is a major causative organism of the tooth cavity. Dissolve sugar to synthesize insoluble dextran. Dextran aggregates oral bacteria, including mutans, to form plaques, and enamel demineralization and cavities are generated by the metabolites (acid) of pragan.
본 명세서에서 언급하는 ‘포르피로모나스 긴기발리스(porphyromonas gingivalis)’는 그람 음성 막대모양의 혐기성 병원균 박테리아로서 치주염과 같은 구강질환을 유발하는 원인균이다. The term " porphyromonas gingivalis " referred to herein is a gram-negative rod-shaped anaerobic pathogenic bacterium that causes oral diseases such as periodontitis.
따라서 본 발명의 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 유효성분으로 포함하는 조성물은 충치유발 원인균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans), 풍치 유발 원인균인 포르피로모나스 긴기발리스(porphyromonas gingivalis)에 대한 우수한 항균활성을 갖는바, 이를 유효성분을 포함하는 본 발명의 조성물은 치주질환 개선(또는 예방) 및 구취제거 효과를 가진 기능성 치약 조성물로서 유용하게 사용될 수 있다.Therefore, the composition comprising the extracts of Aspergillus oryzae, the extract of Aspergillus oryzae and the extract of Aspergillus oryzae as an active ingredient of the present invention can be used as an effective ingredient of the present invention, for example, Streptococcus mutans which is a causative agent of cavities, porphyromonas gingivalis . The composition of the present invention containing the active ingredient can be usefully used as a functional dentifrice composition having an effect of improving (or preventing) periodontal disease and removing bad breath.
본 발명의 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물은 치약 조성물 총 중량에 대하여 0.00001 내지 50.0중량%로 포함될 수 있으며, 조성물에 1μg/ml 내지 100000μg/ml의 농도로 포함될 수 있다. The extracts of Seaweed Extract, Rhododendron syrup extract and Rhododendron syrup extract of the present invention may be contained in an amount of 0.00001 to 50.0% by weight based on the total weight of the dentifrice composition and may be contained in the composition at a concentration of 1 μg / ml to 100,000 μg / ml.
본 발명의 일실시예에 있어서, 상기 치약 조성물은 유효성분으로 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물 이외에 추가적으로 낙지다리(Penthorum chinense Pursh) 추출물을 더 포함할 수 있다.In one embodiment of the present invention, the dentifrice composition may further comprise an extract of Penthorum chinense Pursh as an effective ingredient in addition to the extracts of soybean curd extract, saxifrage extract and bamboo shoot extract.
본 명세서에서 언급하는 ‘낙지다리’는 학명이 Penthorum chinense Pursh이며, 돌나무과의 다년초로서 한방에서 수택란(水澤蘭)이라 하여 활혈, 행수, 자궁출혈, 월경폐지, 수종, 대하, 타박상 등에 약재로 사용하고 있으나, 현재까지 구강 내 세균에 대한 항균 활성에 대한 연구에 대해서는 보고된 바 없다.The term "octopus bridge" referred to in this specification refers to Penthorum chinense Pursh is a perennial plant of the stems. It is used as a medicinal material for the blood-sucking, rowing, uterine bleeding, menstrual abolition, species, No studies have been reported.
본 발명자들은 상기와 같은 특징을 갖는 낙지다리 추출물을 상기 약용식물 추출물(작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물)과 함께 혼합하여 치약 조성물로 제조하는 경우, 구취 유발 원인균인 헬리코박터 파일로리균에 대해서도 우수한 항균성을 가진다는 사실을 규명하였다.The present inventors have found that when octopus legs extracts having the above-described characteristics are mixed with the medicinal plant extracts (soybean curd extract, shrubs extract and bamboo shoot extract) to prepare dentifrice compositions, excellent antimicrobial activity against Helicobacter pylori, Of the total population.
본 발명의 낙지다리 추출물은 낙지다리 건조 분말에 주정(에탄올) 용매를 가하여 추출하는 단계; 추출 여액을 여과한 후 감압 증류하여 농축시키는 단계; 및 농축된 여액을 동결 건조하여 분말화하는 단계를 거쳐 제조될 수 있다.The extract of octopus leg of the present invention is prepared by extracting octopus leg dry powder with a solvent of ethanol (ethanol); Filtering the extracted filtrate, and then concentrating the filtrate by distillation under reduced pressure; And lyophilizing and pulverizing the concentrated filtrate.
본 발명의 치약 조성물은 상기와 같은 유효성분(작두콩 추출물, 소리쟁이 추출물, 족두리풀 추출물, 낙지다리 추출물) 이외에 천일염(또는 죽염 등), 습윤제, 감미제, 증점제, 연마제, 기포제, 착향제, 불소제제, 보존제, 방부제, 색소로 이루어진 군으로부터 선택되는 하나 이상의 첨가제를 추가로 함유할 수 있다.The dentifrice composition of the present invention can be used as a dentifrice composition in addition to the above-mentioned active ingredients (soybean extract, safflower extract, bamboo shoot extract, octopus leg extract), sun salt (or bamboo salt), wetting agent, sweetener, thickener, abrasive, Preservatives, preservatives, pigments, and the like.
본 명세서에서 언급하는 ‘천일염’은 바닷물에 2-3% 함유되어 있는 소금성분을 염전에 끌여들여 햇볕과 바람으로 수분을 자연 증발시켜 정육면체의 소금 결정을 형성하여 만들어진다. 천일염의 주성분은 염화나트륨(Nacl)으로 칼슘, 마그네슘, 칼륨 등의 미네랄 성분이 존재한다. The term "sun-salt" referred to in the present specification is made by forming salt crystals of a cubic body by drawing a salt component containing 2-3% in seawater into a salt and spontaneously evaporating moisture with sunlight and wind. The main component of the salt is sodium chloride (Nacl), which contains minerals such as calcium, magnesium and potassium.
본 명세서에서 언급하는 ‘습윤제’란 치약에 습기와 크림상을 주기 위하여 치약이 공기 중에 접촉하여 고체화되는 것을 방지하기 위한 목적으로 채용되는 성분을 말한다. 그 예로는 D-소르비톨액, 글리세린 또는 폴리에틸렌글리콜 등이 있으며, 통상의 기술자가 적절하게 선택할 수 있다.The term " wetting agent " as used herein refers to a component that is employed for the purpose of preventing the toothpaste from contacting with the air to solidify the toothpick in order to impart moisture and cream to the toothpaste. Examples thereof include D-sorbitol solution, glycerin, polyethylene glycol, and the like, and can be appropriately selected by a person skilled in the art.
본 명세서에서 언급하는 ‘증점제’란 치약의 고체성분과 액체성분의 분리를 방지하기 위한 목적으로 채용되는 성분을 말한다. 그 예로는 카르복시메틸셀룰로오스나트륨 또는 함수규산 등이 있으며, 통상의 기술자가 적절하게 선택할 수 있다.As used herein, the term " thickening agent " refers to a component employed for the purpose of preventing the separation of a solid component and a liquid component of a toothpaste. Examples thereof include sodium carboxymethylcellulose or hydrated silicic acid, and a person skilled in the art can appropriately select them.
본 명세서에서 언급하는 ‘감미제’란 치약에 일정한 미감을 제공하고, 청량감 등을 부여하기 위한 목적으로 채용되는 성분을 말한다. 그 예로는 자일리톨, 스테비올배당체, 삭카린 등이 있으며, 통상의 기술자가 적절하게 선택할 수 있다.As used herein, the term " sweetener " refers to a component that is employed for the purpose of imparting a certain aesthetics to a toothpaste and imparting a cooling sensation and the like. Examples thereof include xylitol, steviol glycoside, and saccarin, and can be appropriately selected by a person skilled in the art.
본 명세서에서 언급하는 ‘연마제’란 치아에 부착된 치구(끈적끈적한 다당질의 막으로 마모작용으로만 제거됨), 치석을 제거하는 역할을 하는 성분을 말한다. 그 예로는 덴탈타입실리카, 함수이산화규소, 콜로이드성이산화규소,침강 실리카, 실리카 겔, 지르코늄 실리케이트, 인산삼칼슘,무수인산칼슘, 인산일수소칼슘, 무수인산일수소칼슘, 이산화규소, 함수알루미나, 침강탄산칼슘, 경질탄산칼슘, 중질탄산칼슘, 피로인산나트륨, 불용성메타인산염 및 알루미늄실리케이트 등이 있으며, 통상의 기술자가 적절하게 선택할 수 있다.The term "abrasive" as used herein refers to a component that acts to remove dental plaque (which is only removed by abrasion with a sticky polysaccharide film) and tartar attached to the teeth. Examples thereof include dental type silica, hydrated silicon dioxide, colloidal silicon dioxide, precipitated silica, silica gel, zirconium silicate, tricalcium phosphate, anhydrous calcium phosphate, calcium monohydrogenphosphate, calcium monohydrogenphosphate anhydrous, silicon dioxide, hydrated alumina, Precipitated calcium carbonate, light calcium carbonate, heavy calcium carbonate, sodium pyrophosphate, insoluble metaphosphate and aluminum silicate, and the like can be appropriately selected by a person skilled in the art.
본 명세서에서 언급하는 ‘기포제’란 연마제의 세정작용을 보완하며 약효제를 칫솔이 도달하기 힘든 부위까지 침투시켜 주는 것은 물론 기포를 발생시켜 양치감을 증대시켜주는 역할을 하며 세정작용을 도와주고 약효제의 분산 및 침투를 빠르게 하고 계면장력을 감소시켜 줌으로 구강 내 이물질이 쉽게 떨어지는 작용을 한다. 그 예로는 음이온 계면활성제인 라우릴 황산나트륨, 알킬황산나트륨이 사용되고 보조적으로 비이온 계면활성제인 폴리옥시에틸렌, 폴리옥시프로필렌, 공중합체, 폴리옥시에틸렌 경화피마자유, 폴리옥시에틸렌 소르비탄 지방산, 알칸올 아미드 지방산 에스테르, 수크로오스 지방산 에스테르, 폴리옥시에틸렌 소르비탄 지방산에스테르, 폴리옥시에틸렌 지방산에스테르 및 폴리옥시에틸렌 아주까리 경화유 유도체등이 있으며, 통상의 기술자가 적절하게 선택할 수 있다.The 'foaming agent' referred to in the present specification supplements the cleaning action of the abrasive, penetrates the hard-to-reach areas where the toothbrush is hard to reach, as well as enhances the feeling of brushing by generating air bubbles. And the interfacial tension is decreased, so that the foreign substances in the oral cavity easily drop. Examples thereof include anionic surfactants such as sodium laurylsulfate and sodium alkylsulfate, as well as nonionic surfactants such as polyoxyethylene, polyoxypropylene, copolymers, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid, alkanolamide Fatty acid esters, sucrose fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene fatty acid esters and polyoxyethylene castor oil hardened oil derivatives, and the like can be appropriately selected by those skilled in the art.
본 명세서에서 언급하는 ‘착향제’란 구강을 깨끗이 하고, 상쾌함을 주며, 구강 내의 불결한 냄새를 억제하기 위한 목적으로 채용되는 성분을 말한다. 그 예로는 페퍼민트오일, 스페아민트오일, 오렌지오일, 라임오일, 레몬오일,L-멘톨,각종 과일 향, 쿨민트향(HF-61399) 또는 조합향료(사과향, HF-30630) 등이 있으며, 통상의 기술자가 적절하게 선택할 수 있다.As used herein, the term " flavoring agent " refers to a component that is employed for the purpose of cleansing the mouth, giving a refreshing feeling, and suppressing the unpleasant odor in the mouth. Examples include Peppermint Oil, Spearmint Oil, Orange Oil, Lime Oil, Lemon Oil, L-Menthol, Fruit Flavor, Cool Mint Flavor (HF-61399) or Combination Flavor (Apple Flavor, HF-30630) May be appropriately selected by a person skilled in the art.
상기에서 언급한 유효성분 및 첨가제를 포함하는 본 발명의 치약 조성물은 액상, 페이스트 또는 투명 겔 타입의 제형일 수 있으나, 치약 조성물로 기능할 수 있는 것이면 어떠한 타입의 제형도 포함하는 개념이며 특별히 그 종류를 한정하는 것은 아니다.The dentifrice composition of the present invention comprising the above-mentioned active ingredients and additives may be a liquid, paste or transparent gel type formulation, but any type of formulation can be used as long as it can function as a dentifrice composition. But is not limited to.
본 발명은 또한, a) 작두콩, 소리쟁이, 족두리풀 각각에 중량 대비 5-10배의 물을 첨가하여 50-60℃ 온도에서 끊여 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 1차 수득하고, 건더기에 다시 물을 처음 용량으로 첨가하여 50-60℃ 온도에서 7-8시간 끊여 처음 용액양의 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 2차 수득한 다음, 이렇게 수득한 1차 추출액과 2차 추출액을 합하여 작두콩 추출물, 소리쟁이 추출물, 족두리풀 추출물 각각을 제조하는 단계; b) 상기 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물 3종을 혼합하는 단계; 및 c) 상기 혼합물에 천일염, 습윤제 및 감미제를 첨가하여 용해시킨 후 증점제, 연마제 및 기포제를 첨가하여 혼합하고 마지막으로 착향제를 첨가하는 단계를 포함하는 치약 조성물 제조방법을 제공한다.The present invention also relates to a method for producing a soybean curd, comprising the steps of: a) adding 5 to 10 times by weight of water to each of soybean curd, soybean curd and shiitake, respectively, at a temperature of 50 to 60 DEG C to obtain a first- , Water was added to the vat in the first volume again, and the vial was cut at a temperature of 50-60 ° C for 7-8 hours to obtain a second volume of the extract except for the vat when the volume became one-third of the initial amount of the solution. Preparing an extract of the soybean curd extract, the extract of Aspergillus oryzae, and the extract of Aspergillus oryzae, respectively, by combining the extract and the secondary extract; b) mixing the soybean curd extract, the safflower extract, and the shoemaker extract; And c) adding a salt, a wetting agent and a sweetening agent to the mixture to dissolve the mixture, adding a thickener, an abrasive, and a foaming agent to the mixture, and finally adding a flavoring agent.
본 발명의 상기 a) 단계는 작두리콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물 각각을 제조하는 단계로서, 자세하게는 작두콩, 소리쟁이, 족두리풀 각각에 중량 대비 5-10배의 물을 첨가하여 50-60℃ 온도에서 끊여 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 1차 수득하고, 건더기에 다시 건더기에 다시 물을 처음 용량으로 첨가한 후 50-60℃ 온도에서 7-8시간 끊여 처음 용액양의 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 2차 수득한 다음, 이렇게 수득한 1차 추출액과 2차 추출액을 합하여 작두리콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물 각각을 제조하는 단계이다.The step a) of the present invention is a step of preparing each of the extracts of Artemisia soiulifolia, Rhododendron japonica extract and Liliaceae. In detail, 5-10 times of water is added to each of soybean curd, When the volume was reduced to 1/3, the extract solution was firstly obtained except for the mackerel. Then, water was added to the mackerel again for the first time, and then the mixture was suspended at 50-60 ° C for 7-8 hours. , And then adding the primary extract and the secondary extract obtained in the above step to each other to prepare the extracts of Artemisia bean extract, Aspergillus oryzae and Aspergillus oryzae respectively.
본 발명의 상기 b) 단계는 작두리콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 배합하여 혼합액을 제조하는 단계로서, 자세하게는 상기 a) 단계를 통해 제조된 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물 각각을 1-5 : 1-5 : 1의 중량비로 혼합하는 단계이다. The step b) of the present invention is a step of preparing a mixed solution by mixing the extracts of Artemisia princescens, Rhododendron syrup extract, and Syrup extract. Specifically, the step of preparing a mixture solution of the extracts of Soybean curd extract, Rhododendron syrup extract and Syrup extract, 1-5: 1-5: 1.
또한, 본 발명의 상기 b) 단계는 상기 a) 단계를 통해 제조된 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물 각각을 1-5 : 1-5 : 1의 중량비로 혼합한 후 50-60℃ 온도에서 수용액 양이 1/2이 될 때까지 끊이는 과정을 통해 혼합물로 제조될 수도 있다. 이는 각각의 추출물을 혼합 사용하는 경우 불편할 수 있는바, 기호에 따라 이들을 혼합한 형태로 제조한 후 필요에 따라 사용할 수 있게 하기 위함이다. 이때, 상기 혼합물은 비중이 1.1 이하가 되도록 하는 것이 바람직하며, 과도하게 농축시켜 비중 1.1를 상회할 경우에는 약용 식물의 유효성분이 파괴되고, 치약 부원료와 혼합 시 잘 혼합이 되지 않거나 한쪽으로 편중되어 혼합될 수 있으므로 피하여야 한다.In step b) of the present invention, the soybean curd extract, the safflower extract, and the safflower extract prepared through step a) are mixed at a weight ratio of 1-5: 1-5: 1, And may be made into a mixture through a process of breaking until the amount of the aqueous solution is 1/2. This is because it may be inconvenient when the respective extracts are mixed and used, so that they can be manufactured in a mixed form according to their preferences and used as needed. At this time, it is preferable that the specific gravity of the mixture is 1.1 or less. If the specific gravity exceeds 1.1, the effective ingredient of the medicinal plant is destroyed. When the mixture is mixed with the tooth paste raw material, It should be avoided.
본 발명의 c) 단계는 상기 b) 단계를 통해 제조된 혼합물에 천일염, 습윤제, 감미제, 증점제, 연마제, 기포제 및 착향제 등을 첨가하는 단계로서, 자세하게는 상기 b) 단계를 통해 제조된 혼합물에 천일염, 습윤제, 감미제를 첨가하여 용해시킨 후 증점제, 연마제, 기포제를 첨가하여 혼합한 다음 마지막으로 착향제를 첨가하는 단계이다.The step c) of the present invention is a step of adding a salt, a wetting agent, a sweetening agent, a thickener, an abrasive, a foaming agent and a flavoring agent to the mixture prepared through the step b) A salt, a wetting agent and a sweetening agent are added and dissolved, and then a thickener, an abrasive and a foaming agent are added and mixed, and finally, a flavoring agent is added.
본 발명의 일실시예에 있어서, 상기 습윤제는 글리세린을 사용할 수 있으며; 상기 감미제는 자일리톨과 솔비톨을 사용할 수 있고; 상기 증점제는 카르복시메틸셀룰로오스를 사용할 수 있으며; 상기 연마제로는 이산화규소를 사용할 수 있고 상기 기포제로는 소듐라우릴설포네이트(Sodium Lauryl Sulfate) 또는 소듐라우로일사르코시네이트(Sodium lauroyl sarcosinate)를 사용할 수 있으나, 특별히 그 종류를 한정하는 것은 아니다.In one embodiment of the present invention, the wetting agent may be glycerin; The sweetener may be xylitol and sorbitol; The thickener may be carboxymethylcellulose; Silicon dioxide may be used as the abrasive, and sodium lauryl sulfate or sodium lauroyl sarcosinate may be used as the foaming agent, but the type thereof is not particularly limited .
본 발명의 일실시예에 있어서, 약용식물 추출물로서 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물 각각은 치약 조성물 총 100중량부를 기준으로 1-10중량부로 포함될 수 있으며; 천일염은 치약 조성물 총 100중량부를 기준으로 하여 1-20중량부로 포함될 수 있고; 습윤제는 치약 조성물 총 100중량부를 기준으로 1-10중량부로 포함될 수 있으며; 감미제는 치약 조성물 총 100중량부를 기준으로 30-70중량부로 포함될 수 있고; 증점제는 치약 조성물 총 100중량부를 기준으로 0.1-5중량부로 포함될 수 있으며; 연마제는 치약 조성물 총 100중량부를 기준으로 5-15중량부로 포함될 수 있고; 기포제는 치약 조성물 총 100중량부를 기준으로 1-10중량부로 포함될 수 있고; 착향제는 치약 조성물 총 100중량부를 기준으로 0.1-5중량부로 포함될 수 있다.In one embodiment of the present invention, each of the soybean curd extract, the safflower extract, and the shoemoleberry extract as the medicinal plant extract may be contained in an amount of 1 to 10 parts by weight based on 100 parts by weight of the toothpaste composition; The sun salt may be contained in an amount of 1-20 parts by weight based on 100 parts by weight of the toothpaste composition; The wetting agent may be present in an amount of 1-10 parts by weight based on 100 parts by weight of the toothpaste composition; The sweetener may be included in an amount of 30 to 70 parts by weight based on 100 parts by weight of the total dentifrice composition; The thickening agent may be included in an amount of 0.1 to 5 parts by weight based on 100 parts by weight of the total dentifrice composition; The abrasive may be included in an amount of 5 to 15 parts by weight based on 100 parts by weight of the toothpaste composition; The foaming agent may be included in an amount of 1 to 10 parts by weight based on 100 parts by weight of the toothpaste composition; The flavoring agent may be included in an amount of 0.1 to 5 parts by weight based on 100 parts by weight of the total dentifrice composition.
이하, 실시예를 통하여 본 발명을 보다 상세히 설명하고자 한다. 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are for further illustrating the present invention, and the scope of the present invention is not limited to these examples.
<< 실시예Example 1> 1>
약용식물 추출물 준비Preparation of medicinal plant extract
<1-1> 작두콩 추출물의 제조<1-1> Preparation of Soybean Extract
본 발명에 사용한 작두콩(콩, 꼬투리)은 2015년 10월 문경시 이화농장에서 채취한 것을 물로 깨끗이 세척하여 사용하였다. 콩은 1/2로 절개하고 꼬투리는 약제용 작두를 이용하여 약 1-2mm 크기로 잘라 준비한 다음 건조하였다. 건조과정은 채반에 받쳐 3일 내지 일주일간 음건 풍수하거나 또는 식품 건조기를 이용하여 수분 함량이 10%이내까지 되도록 10-14시간 건조시킬 수 있다.Soybean (pods) used in the present invention was collected in October 2015 from Ewha Farm, Mungyeong, and cleaned with water and used. The soybeans were cut in half and the pods were cut to a size of about 1 to 2 mm using a tablet for medicine and then dried. The drying process can be carried out for 3 to 7 days on shrubs, or dried for 10-14 hours using a food drier until the moisture content is within 10%.
상기와 같은 과정을 통해 준비한 작두콩 1kg에 물 5kg을 첨가하여 1시간 동안 수침하는 과정을 통해 물이 작두콩에 완전히 침지되도록 한 후 50-60℃ 온도에서 7-8시간 끊여 처음 용액양의 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 1차 수득하고, 건더기에 다시 물 5kg을 첨가하여 50-60℃ 온도에서 7-8시간 끊여 처음 용액양의 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 2차 수득하였다. 이렇게 수득한 1차 추출액과 2차 추출액을 합하여 작두콩 추출물을 제조하였다.5 kg of water was added to 1 kg of soybean koji prepared by the above procedure, and water was soaked for 1 hour, so that the water was completely immersed in soybean koji. Then, it was cut at 50-60 ° C for 7-8 hours, , The extract solution was firstly obtained, and 5 kg of water was added again to the mackerel, which was then terminated at 50-60 ° C for 7-8 hours. When the volume became 1/3 of the initial amount of the solution, the extract solution except the mackerel Lt; / RTI > The thus obtained primary extract and secondary extract were combined to prepare a soybean curd extract.
<1-2> 소리쟁이 추출물의 제조<1-2> Preparation of Syrup extract
본 발명에 사용한 소리쟁이는 2015년 8월 천안시 성거산에서 직접 채취하여 사용하였다. 소리쟁이의 잎과 뿌리를 모두 사용하였으며, 이때 소리쟁이 잎은 물로 깨끗하게 세척한 뒤 3-4 mm 크기로 준비하였고 뿌리는 물로 깨끗하게 세척한 뒤 1-2mm의 크기로 잘라 준비한 다음 상기 실시예 <1-1>과 동일한 방법으로 건조하였다.The spider used in the present invention was directly collected at Seonggi Mountain in Cheonan Province in August 2015. The roots were washed with water and cleaned. The roots were washed with water and then cut to a size of 1-2 mm. Then, the roots were washed with water, -1 >.
상기와 같은 과정을 통해 준비한 소리쟁이 1kg에 물 5kg을 첨가하여 1시간 동안 수침하는 과정을 통해 물이 소리쟁이에 완전히 침지되도록 한 후 50-60℃ 온도에서 7-8시간 끊여 처음 용액양의 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 1차 수득하고, 건더기에 다시 물 5kg을 첨가하여 50-60℃ 온도에서 7-8시간 끊여 처음 용액양의 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 2차 수득하였다. 이렇게 수득한 1차 추출액과 2차 추출액을 합하여 소리쟁이 추출물을 제조하였다.5 kg of water was added to 1 kg of syrup prepared by the above procedure, and water was soaked in the syringe for 1 hour. After the water was completely immersed in the syringe, it was withdrawn at 50-60 ° C for 7-8 hours, / 3, the extract was firstly obtained except for the gherkin, and 5 kg of water was added again to the gherkin and the mixture was cut at 50-60 ° C for 7 to 8 hours. When the volume of the solution reached 1/3 of the initial amount of the solution, Secondary extracts were obtained. The first extract and the second extract obtained as described above were combined to prepare a safflower extract.
<1-3> <1-3> 족두리풀Bamboo shoot 추출물의 제조 Preparation of extract
본 발명에 사용한 족두리풀은 2015년 9월 천안시 태조산에서 직접 채취하여 사용하였다. 족두리풀은 물로 깨끗하게 세척한 뒤 3-4 mm 크기로 준비한 다음 상기 실시예 <1-1>과 동일한 방법으로 건조하였다.The ladybug used in the present invention was directly collected at Taejo Mountain, Cheonan Province in September 2015. The shoehorns were cleaned with water and then prepared in a size of 3-4 mm, followed by drying in the same manner as in Example <1-1>.
상기와 같은 과정을 통해 준비한 족두리풀 1kg에 물 5kg을 첨가하여 1시간 동안 수침하는 과정을 통해 물이 족두리풀에 완전히 침지되도록 한 후 50-60℃ 온도에서 7-8시간 끊여 처음 용액양의 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 1차 수득하고, 건더기에 다시 물 5kg을 첨가하여 50-60℃ 온도에서 7-8시간 끊여 처음 용액양의 1/3의 부피가 되었을 때 건더기를 제외한 추출액을 2차 수득하였다. 이렇게 수득한 1차 추출액과 2차 추출액을 합하여 족두리풀 추출물을 제조하였다.5 kg of water was added to 1 kg of the prepared shoe lilies prepared by the above process, and water was soaked for 1 hour, so that the water was completely immersed in the shrimp, and then the shrimp was cut at 50-60 ° C for 7-8 hours, , The extract solution was firstly obtained, and 5 kg of water was added again to the mackerel, which was then terminated at 50-60 ° C for 7-8 hours. When the volume became 1/3 of the initial amount of the solution, the extract solution except the mackerel Lt; / RTI > The first extract and the second extract thus obtained were combined to produce an extract of Lycopersicon esculentum.
<1-4> 대극 추출물의 제조≪ 1-4 > Production of a counter electrode extract
본 발명에 사용한 대극(Euphorbia pekinensis RUPR .)의 지상부는 2014년 5월 수원 서둔동에서 채취하여 시료로 이용하였다. 채취된 대극 지상부는 세척, 건조시킨 후 분쇄하여 분말로 만들어 가속용매추출장치 (accelerated solvent extractor, ASE)를 이용해 50℃에서 메탄올로 추출하였고 추출액을 여과한 후에 회전증발농축기(Rotary Evaporator)로 감압 농축하여 용매를 제거하였다. 대극 지상부 분말 100g으로부터 얻어진 추출물은 16g이었다.The upper part of the counter pole ( Euphorbia pekinensis RUPR . ) Used in the present invention was collected in May, 2014 from Seodong-dong Suwon and used as a sample. The ground part of the recovered main pole was washed, dried and pulverized into powders. The powder was extracted with methanol using an accelerated solvent extractor (ASE) at 50 ° C. The extract was filtered and then concentrated under reduced pressure using a rotary evaporator To remove the solvent. The amount of the extract obtained from 100 g of the groundwater phase powder was 16 g.
<1-5> 꽈리 추출물의 제조<1-5> Preparation of chrysanthemum extract
본 발명에 사용한 꽈리(Physalis alkekengi var. francheti (Mast.) Hort)의 지상부는 2014년 7월 수원 서둔동에서 채취하여 시료로 이용하였다. 채취된 꽈리 지상부는 세척, 건조시킨 후 분쇄하여 분말로 만들어 가속용매추출장치 (accelerated solvent extractor, ASE)를 이용해 50℃에서 메탄올로 추출하였고 추출액을 여과한 후에 회전증발농축기(Rotary Evaporator)로 감압 농축하여 용매를 제거하였다. (중국)꽈리 지상부 분말 100g으로부터 얻어진 추출물은 10g이었다. Alveolar used in the present invention (Physalis There is alkekengi . The top part of the francheti (Mast.) Hort was collected in July 2014 in Seodong-dong Suwon and used as a sample. The extracted acicular ground part was washed, dried and then pulverized into powders. The powder was extracted with methanol using an accelerated solvent extractor (ASE) at 50 ° C. The extract was filtered and then concentrated under reduced pressure using a rotary evaporator To remove the solvent. (China) 10 g of the extract obtained from 100 g of the chrysanthemum ground powder was 10 g.
<1-6> 낙지다리 추출물의 제조<1-6> Preparation of Octopus Leg Extract
본 발명에 사용한 낙지다리(Penthorum chinense Pursh)의 지상부는 2014년 7월 수원 서둔동에서 채취하여 시료로 이용하였다. 채취된 낙지다리 지상부는 세척, 건조시킨 후 분쇄하여 분말로 만들어 가속용매추출장치 (accelerated solvent extractor, ASE)를 이용해 85℃에서 에탄올로 추출하였고 추출액을 여과한 후에 회전증발농축기로 감압 농축하여 용매를 제거하였다. 낙지다리 지상부 분말 165g으로 부터 얻어진 추출물은 28g이었다. The octopus legs ( Penthorum chinense Pursh ) was collected in July 2014 in Seodong-dong Suwon and used as a sample. The ground portion of the harvested octopus legs was washed, dried and pulverized to powder. The powder was extracted with ethanol using an accelerated solvent extractor (ASE) at 85 ° C. The extract was filtered and concentrated under reduced pressure using a rotary evaporator to obtain a solvent Respectively. The extract obtained from 165g of octopus leg root powder was 28g.
이렇게 수득한 각각의 추출물은 4℃에서 냉장보관하면서 하기 실험의 시료로 사용하였다. 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물은 액상으로 제조되었으며; 대극 추출물, 꽈리 추출물 및 낙지다리 추출물은 분말로 제조되었다.Each of the extracts thus obtained was used as a sample for the following experiment while being stored at 4 ° C in a refrigerator. The extracts of soybean curd, rosemary extract and bamboo shoots were prepared in liquid form; The major pole extract, kelp extract and octopus leg extract were prepared as powder.
<< 실시예Example 2> 2>
단독 약용식물 추출물의 항균 효과Antibacterial effect of single medicinal plant extracts
본 발명자는 상기 <실시예 1>을 통해 제조된 각각의 약용식물 추출물의 항균 효과를 실험하였다.The present inventors have examined the antibacterial effect of each of the medicinal plant extracts prepared in Example 1 above.
항균 효과 실험을 위해 충치유발 원인균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans) 균에 대한 억제 활성을 살펴보았다. For the antimicrobial effect test, the inhibitory activity against Streptococcus mutans was examined.
항균 효과는 디스크 확산법으로 평가하였다. 즉, 균주는 OD 600 nm에서 측정값이 0.5가 될 때 까지 37℃에서 TBS 배지에 배양하였다. 약 104~105 CFU/ml 농도의 배양액 100 ul를 MHA agar 배지에 도말하였다. 디스크(지름 6mm)에 각각의 추출물을 1 mg과 5 mg을 첨가하여 디스크를 위의 MHA 배지에 올려두었다. 37℃에서 24시간동안 배양한 뒤 미생물을 배양한 고체배지에서 억제구간(inhibition zone)의 지름을 측정하였다. 실험은 3회 반복하여 진행하고, 그 평균값을 나타내었다.The antimicrobial effect was evaluated by disk diffusion method. That is, the strain was cultured in TBS medium at 37 ° C until the measured value was 0.5 at OD 600 nm. 100 μl of culture at a concentration of about 10 4 to 10 5 CFU / ml was plated on MHA agar medium. 1 mg and 5 mg of each extract was added to the disk (diameter 6 mm) and the disk was placed on the above MHA medium. After incubation at 37 ° C for 24 hours, the diameter of the inhibition zone was measured in the solid medium in which the microorganism was cultured. The experiment was repeated three times and the average value was shown.
추출물Soybean
extract
추출물Shout
extract
추출물Antipode
extract
추출물ground cherry
extract
<< 실시예Example 3> 3>
약용식물 추출물을 포함하는 치약 조성물 제조Manufacture of toothpaste compositions comprising medicinal plant extracts
하기 실험에서 사용한 천일염은 전북 부안 곰소염전에서 구입하였으며; 글리세린(Glycerine)은 LG생활건강으로부터 구입하였고; 자일리톨(Xylitol)은 보락에서 구입하였으며; 솔비톨(Sorvitol)은 백광화학에서 구입하였고, 증점제(CMC-Na;Sodium carboxymethylcellulose)는 보락으로부터 구입하였으며, 이산화규소(Silcon dioxide)는 우주산업으로부터 구입하였고; 기포제(SLS ;Sodium lauryl sulfate / Miami L95 ;Sodium lauroyl sarcosinate)는 미원상사로부터 구입하였다.The solar salt used in the following experiment was purchased from Bujang Gomso Tidal Flat, Jeonbuk Province; Glycerine was purchased from LG Household & Health Care; Xylitol was purchased from Borac; Sorvitol was purchased from Kwangwang Chemical; thickener (CMC-Na) was purchased from Borac; silicon dioxide was purchased from space industry; Sodium lauroyl sarcosinate (SLS; sodium lauryl sulfate / Miami L95) was purchased from Miwon.
본 발명자는 약용 식물로서 상기 <실시예 1>을 통해 준비한 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 혼합하여 치주질환 예방과 플라그 억제에 최적의 효과를 보이는 혼합비를 도출하기 위하여 실험을 진행하였다.The present inventors conducted an experiment to obtain mixing ratios having the optimum effects for preventing periodontal disease and suppressing plaque by mixing the extracts of the soybean curd extract, the extract of Aspergillus oryzae and the extract of Aspergillus oryzae, prepared through the <Example 1> as a medicinal plant.
자세하게는 본 발명의 상기 <실시예 1>을 통해 준비한 작두콩 추출물, 소리쟁이추출물, 족두리풀 추출물을 하기 표 2의 중량비로 넣고 혼합하였다. 이후 천일염, 글리세린, 자일리톨, 솔비톨을 순차 투입하고 모두 용해되도록 고루 교반하였다. 여기에 다시 카르복시메틸셀룰로오스, 이산화규소, 기포제를 넣고 마지막으로 박하향을 첨가하여 최종 치약 조성물을 제조하였다. 첨가되는 구성성분의 중량비는 아래 표 2와 같다.In detail, the soybean curd extract, the safflower extract, and the safflower extract prepared through Example 1 of the present invention were mixed at a weight ratio shown in Table 2 below. Then, the mixture was stirred with gentle saline, glycerin, xylitol and sorbitol in order to dissolve them all at once. The final dentifrice composition was prepared by adding carboxymethyl cellulose, silicon dioxide, foaming agent and finally adding pepper powder. The weight ratios of the constituents added are shown in Table 2 below.
<< 실시예Example 4> 4>
본 발명의 치약 조성물의 The dentifrice composition of the present invention 사용감 등Feeling 평가 evaluation
<4-1> 잇몸질환이 없는 일반인 대상의 <4-1> For people without gum disease 사용감Feeling 평가 evaluation
치주질환이 없는 40세 이상 50명(남 30명, 여 20명)을 대상으로 본 발명의 실시예 T1~T10 총 10종류의 치약을 사용하게 하고, 하기의 항목을 조사하여 그 평균값에 대한 결과를 하기 표로 나타내었다.Ten toothpaste samples of Examples T1 to T10 of the present invention were used for 50 persons (30 males and 20 females) aged 40 years or over without periodontal disease, and the following items were examined and the results Are shown in the following table.
평가는 5점 척도이며, 5-매우 좋음, 4-좋음, 3-보통, 2-나쁨, 1-매우 나쁨으로 평가하도록 하였다.The evaluation was scored on a 5-point scale and was rated as 5-excellent, 4-good, 3-normal, 2-poor, and 1-very bad.
그 결과 상기 표 3에서 나타낸 바와 같이, 실시예 T1 내지 T4의 경우 T5 내지 T10과 비교하여 전체적인 만족도가 매우 높게 나타났으며, 그 총점 차이도 2배 가까이 됨을 확인할 수 있었다.As a result, as shown in Table 3, it can be seen that the overall satisfaction is higher than that of T5 to T10 in Examples T1 to T4, and that the total score difference is nearly double.
<4-2> 잇몸질환이 있는 피검자를 대상의 잇몸치료 및 구취제거 효과 측정<4-2> Measurement of gum treatment and bad breath removal effect on subjects with gum disease
치주염, 잇몸출혈, 이가 시린 증상 등의 잇몸질환과 구취가 있는 피검자 100 명을 선별한 후 그들을 임의로 10 명씩 10 개의 군으로 나누었다. 10 개의 군으로 나눈 피검자 10 명에게 4 주 동안 실시예 T1 내지 T10에서 제조한 치약을 1 일 3 회 사용하게 하였다.100 subjects with periodontal disease, gingival bleeding, gingivitis, gingival diseases and bad breath were selected, and then randomly divided into 10 groups of 10 persons. 10 subjects divided into 10 groups were allowed to use the toothpaste prepared in Examples T1 to T10 three times a day for 4 weeks.
잇몸질환 치료효과 측정은 각 실험군의 피검자를 대상으로 실시예 T1 내지 T10에서 제조한 치약을 4 주간 사용하게 한 후에 치주염, 잇몸출혈, 이가 시림 등의 잇몸질환에 대한 치료 만족도를 5 점 척도 기준으로 평가한 뒤, 그 평균값을 측정하였다. 평가는 5점 척도이며, 1 점: 매우 불만족, 2 점: 불만족, 3 점: 보통, 4 점: 만족, 5 점: 매우 만족으로 평가하게 하였다.The gingival disease therapeutic effect was measured by using the toothpaste manufactured in Examples T1 to T10 for 4 weeks for the subjects of each experimental group, and then the degree of treatment satisfaction for gum disease such as periodontitis, gum bleeding, After the evaluation, the average value was measured. The evaluation was on a scale of 5 points. One point: Very unsatisfied, 2 points: Dissatisfied, 3 points: Average, 4 points: Satisfaction, 5 points: Very satisfied.
한편, 구취제거 효과 측정은 각 실험군의 피검자를 대상으로 T1 내지 T10 에서 제조한 치약을 사용하기 전 (실험 전 및 양치질 전)과 4 주간 사용한 후 (실험 후 및 양치질 직후) 의 구취정도를 메타(Halimeter)로 측정한 뒤, 그 평균값을 대비하였다.On the other hand, the measurement of the odor elimination effect was carried out by measuring the degree of bad breath of the subjects of each experimental group before (before the experiment) and after using the toothpaste (after the experiment and after the rinse) Halimeter), and the mean value was compared.
그 결과 상기 표 4에서 나타낸 바와 같이, T1-T4의 경우 T5-T10과 비교하여 잇몸질환 치료 및 구취제거 효과가 두드러지게 우수한 것을 확인할 수 있었다. As a result, as shown in Table 4, it was confirmed that T1-T4 was superior to T5-T10 in the treatment of gum disease and bad breath removal.
본 발명자는 상기와 같은 효과가 충치유발 원인균의 활성 억제를 통한 항균 및 항염증 효과에 기인하는 것으로 판단하였다. 이에, 실제적으로 이러한 효과가 있는지 살펴보기 위하여 추가적인 항균 효과에 대하여 실험을 진행하였다.The inventors of the present invention have determined that the above-mentioned effects are attributable to the antibacterial and anti-inflammatory effects through inhibition of the activity of the causative bacteria. In order to see if there is actually such an effect, an additional antibacterial effect was experimented.
<< 실시예Example 5> 5>
본 발명의 치약 조성물의 항균 효과The antimicrobial effect of the dentifrice composition of the present invention
본 실험에서는 상기 <실시예 3>을 통해 제조된 치약 조성물의 항균 효과를 실험하기 위하여, 스트렙토코쿠스 뮤탄스(Streptococcus mutans), 포르피로모나스 긴기발리스(porphyromonas gingivalis), 헬리코박터 파일로리(Helicobacter pylori) 균에 대한 억제 활성을 살펴보았다.In order to test the antibacterial effect of the dentifrice composition prepared in Example 3, Streptococcus mutans , porphyromonas gangrene, gingivalis ) and Helicobacter pylori ( Helicobacter pylori ).
먼저, 충치유발 원인균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans), 풍치 유발 원인균인 포르피로모나스 긴기발리스(porphyromonas gingivalis) 및 구취 유발 원인균인 헬리코박터 파일로리(Helicobacter pylori)에 대한 최저저지농도(minimal inhibitory concentration, MIC)를 측정하였다. 측정방법은 액체 배지 희석법(broth dilution method)을 사용하여 측정하였는데, 먼저 치약 조성물을 정제수에 100배 희석하고, 5ml의 액체 배지에 28 까지 2배수 단계 희석한 후, 균을 접종했다. 37℃, 5% CO2 의 환경에서 3시간 동안 배양하여, 균주의 증식이 관찰되지 않은 온도를 MIC로 판정하였다. MIC판정 결과는 하기 표에 나타내었다.First, Streptococcus mutans , a causative organism causing cavities, and porphyromonas ( porphyromonas) gingivalis ) and the minimum inhibitory concentration (MIC) for Helicobacter pylori , a causative organism causing bad breath. The measuring method was measured using a broth dilution method. First, the dentifrice composition was diluted 100 times with purified water, diluted twice to 28 with 5 ml of liquid medium, and then inoculated with the bacteria. The cells were cultured in an environment of 37 ° C and 5% CO 2 for 3 hours, and the temperature at which no growth of the strain was observed was determined as MIC. The MIC determination results are shown in the following table.
그 결과 상기 표 5에서 나타낸 바와 같이, T1-T4의 경우 T5-T10과 비교하여 충치유발 원인균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans), 풍치 유발 원인균인 포르피로모나스 긴기발리스(porphyromonas gingivalis)에 대한 항균 활성이 두드러지게 우수한 것을 확인할 수 있었다. 이에 반해, 헬리코박터 파일로리(Helicobacter pylori)에 대한 항균활성은 거의 없는 것으로 나타났다.As a result, as shown in Table 5, in the case of the T1-T4 in comparison to T5-T10 caries causing organisms of streptococcus mutans (Streptococcus mutans), taste causing organisms in long Pseudomonas formate fatigue eccentricity Lees (porphyromonas gingivalis) It was confirmed that the antimicrobial activity was remarkably excellent. On the other hand, there was little antimicrobial activity against Helicobacter pylori .
<< 실시예Example 6> 6>
추가적인 약용식물 추출물을 부가한 치약 조성물 제조Manufacture of toothpaste compositions with additional medicinal plant extracts
본 발명자는 상기 <실시예 3>을 통해 제조된 본 발명의 치약 조성물에 추가적으로 첨가하여 치주질환 억제 효과의 효능을 증진시킬 수 있는 소재를 찾고자 하였으며, 후보군으로 상기 실시예 1에서 준비한 대극 추출물(실시예 <1-4>), 꽈리 추출물(실시예 <1-5>) 및 낙지다리 추출물(실시예 <1-6>)을 이용하였다.The inventor of the present invention intends to find a material capable of enhancing the effectiveness of the periodontal disease-suppressing effect by additionally adding to the dentifrice composition of the present invention prepared through the above Example 3. As a candidate group, the antipark extract prepared in Example 1 (Example <1-5>) and octopus leg extract (Example <1-6>) were used.
자세하게는 본 발명의 상기 <실시예 1>을 통해 준비한 작두콩 추출액, 소리쟁이추출물, 족두리풀 추출물, 대극 추출물, 꽈리 추출물, 낙지다리 추출물을 하기 표의 중량비로 넣고 혼합하였다. 이후 천일염, 글리세린, 자일리톨, 솔비톨을 하기 표의 중량비로 순차 투입하고 모두 용해되도록 고루 교반하였다. 여기에 다시 카르복시메틸셀룰로오스, 이산화규소, 기포제를 하기 표의 중량비로 넣고 마지막으로 박하향을 첨가하여 최종 치약 조성물을 제조하였다.In detail, soybean curd extract, sardine extract, bamboo shoot extract, Diptera extract, corn root extract and octopus leg extract prepared through Example 1 of the present invention were mixed at the weight ratios shown below. Then, the mixture was stirred at a weight ratio shown in the following table, and the mixture was stirred so that all of the salts were dissolved. Carboxymethylcellulose, silicon dioxide and foaming agent were again added thereto in the weight ratios shown in the following table, and finally, a peppermint was added to prepare a final dentifrice composition.
<< 실시예Example 7> 7>
추가적인 약용식물 추출물을 부가한 치약 조성물의 Of a dentifrice composition to which an additional medicinal plant extract has been added 사용감 등Feeling 평가 evaluation
<7-1> 잇몸질환이 없는 일반인 대상의 <7-1> For people without gum disease 사용감Feeling 평가 evaluation
치주질환이 없는 40세 이상 50명(남 30명, 여 20명)을 대상으로 본 발명의 T11-T16 총 6종의 치약을 사용하게 하고, 하기의 항목을 조사하여 그 평균값에 대한 결과를 하기 표로 나타내었다.Sixty toothpastes of T11-T16 of the present invention were used in 50 persons (40 males and 20 females) aged 40 years or over without periodontal disease, and the following items were examined and the results of the mean values were shown Respectively.
평가는 5점 척도이며, 5-매우 좋음, 4-좋음, 3-보통, 2-나쁨, 1-매우 나쁨으로 평가하도록 하였다.The evaluation was scored on a 5-point scale and was rated as 5-excellent, 4-good, 3-normal, 2-poor, and 1-very bad.
그 결과 상기 표 7에서 나타낸 바와 같이, T11 내지 T16의 경우 전체적인 만족도가 매우 높게 나타났으며, 실험군별 사용감 차이는 크지 않았다.As a result, as shown in Table 7, the overall satisfaction was high in T11 to T16, and there was not a large difference in feeling among the experimental groups.
<7-2> 잇몸질환이 있는 피검자를 대상의 잇몸치료 및 구취제거 효과 측정<7-2> Measuring gum treatment and bad breath removal effect on subjects with gum disease
치주염, 잇몸출혈, 이가 시린 증상 등의 잇몸질환과 구취가 있는 피검자 60 명을 선별한 후 그들을 임의로 10 명씩 6 개의 군으로 나누었다. 6 개의 군으로 나눈 피검자 10 명에게 4 주 동안 제조한 치약을 1 일 3 회 사용하게 하였다.Sixty subjects with gum disease and bad breath, such as periodontitis, gum bleeding, and irritable bowel syndrome, were selected and randomly divided into six groups of ten. Ten subjects who were divided into six groups were allowed to use toothpaste manufactured for four weeks three times a day.
잇몸질환 치료효과 측정은 각 실험군의 피검자를 대상으로 T11-T16에서 제조한 치약을 4 주간 사용하게 한 후에 치주염, 잇몸출혈, 이가 시림 등의 잇몸질환에 대한 치료 만족도를 5 점 척도 기준으로 평가한 뒤, 그 평균값을 측정하였다. 평가는 5점 척도이며, 1 점: 매우 불만족, 2 점: 불만족, 3 점: 보통, 4 점: 만족, 5 점: 매우 만족으로 평가하게 하였다.The gingival disease treatment effect was measured by using the toothpaste manufactured by T11-T16 for 4 weeks for subjects in each experimental group, and then the degree of treatment satisfaction with gum disease such as periodontitis, gum bleeding and iridescence was evaluated on a 5 point scale Then, the average value was measured. The evaluation was on a scale of 5 points. One point: Very unsatisfied, 2 points: Dissatisfied, 3 points: Average, 4 points: Satisfaction, 5 points: Very satisfied.
한편, 구취제거 효과 측정은 각 실험군의 피검자를 대상으로 T11-T16에서 제조한 치약을 사용하기 전 (실험 전 및 양치질 전)과 4 주간 사용한 후 (실험 후 및 양치질 직후) 의 구취정도를 메타(Halimeter)로 측정한 뒤, 그 평균값을 대비하였다.On the other hand, the odor elimination effect was measured by measuring the degree of bad breath of the subjects of each experimental group before (before and after the experiment) and after using the toothpaste manufactured by T11-T16 (before and after the experiment) Halimeter), and the mean value was compared.
그 결과 상기 표 8에서 나타낸 바와 같이, 낙지다리 추출물을 추가로 더 포함하는 T13 및 T16에서 잇몸질환 치료 및 구취제거 효과가 더욱 증진되는 것을 확인할 수 있었다. As a result, as shown in Table 8, it was confirmed that the treatment for gum disease and the removal of bad breath were further enhanced in T13 and T16, which further included octopus legs extract.
본 발명자는 상기와 같은 효과가 충치유발 원인균의 활성 억제를 통한 항균 및 항염증 효과에 기인하는 것으로 판단하였다. 이에, 실제적으로 이러한 효과가 있는지 살펴보기 위하여 추가적인 항균 효과에 대하여 실험을 진행하였다.The inventors of the present invention have determined that the above-mentioned effects are attributable to the antibacterial and anti-inflammatory effects through inhibition of the activity of the causative bacteria. In order to see if there is actually such an effect, an additional antibacterial effect was experimented.
<< 실시예Example 8> 8>
추가적인 약용식물 추출물 첨가한 본 발명의 치약 조성물의 항균 효과The antimicrobial effect of the dentifrice composition of the present invention added with an additional medicinal plant extract
본 실험에서는 상기 <실시예 6>을 통해 제조된 치약 조성물의 항균 효과를 실험하기 위하여, 스트렙토코쿠스 뮤탄스(Streptococcus mutans), 포르피로모나스 긴기발리스(porphyromonas gingivalis), 헬리코박터 파일로리(Helicobacter pylori) 균에 대한 억제 활성을 살펴보았다.In order to test the antimicrobial effect of the dentifrice composition prepared in Example 6, Streptococcus mutans , porphyromonas gangrene, gingivalis ) and Helicobacter pylori ( Helicobacter pylori ).
실험과정을 상기 <실시예 5>와 동일하게 진행되었으며, MIC판정 결과는 하기 표에 나타내었다.The experimental procedure was the same as in Example 5, and the MIC determination results are shown in the following table.
그 결과 상기 표 9에서 나타낸 바와 같이, 낙지다리 추출물을 추가로 더 포함하는 T13 및 T16의 경우 다른 실험군에 비해 충치유발 원인균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans), 풍치 유발 원인균인 포르피로모나스 긴기발리스(porphyromonas gingivalis)에 대한 항균 활성이 두드러지게 우수할 뿐만 아니라, 구취 유발 원인균에 해당하는 헬리코박터 파일로리(Helicobacter pylori)에 대한 항균활성도 우수한 것을 확인 할 수 있었다.As a result, as shown in Table 9, in the case of T13 and T16, which further included octopus legs extract, Streptococcus mutans , a causative organism causing cavities, and Porphyromonas long, The antimicrobial activity against porphyromonas gingivalis was remarkably excellent, and the antimicrobial activity against Helicobacter pylori , which is a cause of bad breath, was also excellent.
종합적으로 작두콩 추출물, 소리쟁이 추출물 및 족두리풀 추출물을 특정 배합비로 포함하는 치약 조성물의 경우 치주질환 치료(또는 예방) 효과가 우수함을 실험을 통해 확인하였으며, 특히 낙지다리(Penthorum chinense Pursh) 추출물을 추가적으로 더 포함하여 제조한 치약 조성물의 경우 충치유발 원인균의 우수한 억제 활성과 더불어 구취 유발균인 헬리코박터 파일로리균의 억제 활성도 가짐에 따라 치약 소재로서 가장 우수한 효과를 이끌어 낼 수 있었다.Overall jakdukong extract, ivy extract, and when the sound of the dentifrice composition comprising the extract in a specific mixing ratio jokduripul periodontal diseases treatment (or prevention) effects were confirmed through experiments the superior, especially octopus legs (Penthorum chinense Pursh extract of the present invention has an excellent inhibitory activity on the causative bacteria of tooth decay and also has an inhibitory activity on Helicobacter pylori as a bad breath inducing microorganism.
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.The present invention has been described with reference to the preferred embodiments. It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Therefore, the disclosed embodiments should be considered in an illustrative rather than a restrictive sense. The scope of the present invention is defined by the appended claims rather than by the foregoing description, and all differences within the scope of equivalents thereof should be construed as being included in the present invention.
Claims (7)
상기 조성물은 작두콩 추출물, 소리쟁이 추출물, 족두리풀 추출물 및 낙지다리 추출물을 유효성분으로 포함하고,
상기 작두콩 추출물, 소리쟁이 추출물, 족두리풀 추출물 및 낙지다리 추출물은 1-5 : 1-5 : 1 : 0.1-0.2의 중량비로 포함하며,
상기 조성물은 충치유발 원인균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans), 풍치 유발 원인균인 포르피로모나스 긴기발리스(porphyromonas gingivalis) 및 구취 유발 원인균인 헬리코박터 파일로리(Helicobacter pylori)에 대한 모든 균에 대해 항균활성을 갖는 것을 특징으로 하는 치약 조성물.As toothpaste compositions,
Wherein said composition comprises as an active ingredient soybean curd extract, safflower extract, bamboo shoot extract and octopus leg extract,
The extracts of the above mentioned soybean curd extract, safflower extract, bamboo shoot extract and octopus leg are contained in a weight ratio of 1-5: 1-5: 1: 0.1-0.2,
The above composition has antibacterial activity against all bacteria against Streptococcus mutans which is a causative organism causing cavities, Porphyromonas gingivalis which is a causative agent of the taste, and Helicobacter pylori which is a cause of bad breath by Helicobacter pylori And a dentifrice composition.
상기 추출물을 열수추출물인 것을 특징으로 하는 치약 조성물.The method according to claim 1,
Wherein the extract is a hot-water extract.
상기 치약 조성물은 액상, 페이스트 또는 투명 겔 타입의 제형인 것을 특징으로 하는 치약 조성물.3. The method according to claim 1 or 2,
Wherein the dentifrice composition is a liquid, paste, or transparent gel type formulation.
b) 상기 작두콩 추출물, 소리쟁이 추출물, 족두리풀 추출물 및 낙지다리 추출물 4종을 1-5 : 1-5 : 1 : 0.1-0.2의 중량비로 혼합하는 단계; 및
c) 상기 혼합물에 천일염, 습윤제 및 감미제를 첨가하여 용해시킨 후 증점제, 연마제 및 기포제를 첨가하여 혼합하고 마지막으로 착향제를 첨가하는 단계를 포함하는 치약 조성물 제조방법.a) 5-10 times water by weight is added to each of alfalfa, sorghum and bamboo shoots at a temperature of 50-60 < [deg.] > C, and when the volume becomes 1/3 of the volume, the extract is firstly obtained except for the gherkin, Was added for the first time, and the mixture was cut at a temperature of 50-60 ° C for 7-8 hours. When the volume became one-third of the initial amount of the solution, the extract solution except the mulch was secondarily obtained. Preparing an extract of Octopus legume by adding ethanol to the dry powder of the octopus legs;
b) mixing the four kinds of the extracts of the above mentioned soybean curd extract, Sepharose extract, Leaf extract, and Octopus legs at a weight ratio of 1-5: 1-5: 1: 0.1-0.2; And
c) adding to the mixture a salt, a wetting agent and a sweetening agent to dissolve, adding a thickener, an abrasive, and a foaming agent to the mixture, and finally adding a flavoring agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160033805A KR101782858B1 (en) | 2016-03-22 | 2016-03-22 | Toothpaste composition comprising of medicinal plants |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160033805A KR101782858B1 (en) | 2016-03-22 | 2016-03-22 | Toothpaste composition comprising of medicinal plants |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101782858B1 true KR101782858B1 (en) | 2017-09-29 |
Family
ID=60035389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160033805A Active KR101782858B1 (en) | 2016-03-22 | 2016-03-22 | Toothpaste composition comprising of medicinal plants |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101782858B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111000752A (en) * | 2020-01-06 | 2020-04-14 | 陕西润和堂医药有限公司 | Traditional Chinese medicine toothpaste for resisting helicobacter pylori |
KR20210047451A (en) * | 2019-10-22 | 2021-04-30 | (주)성원화장품 | Composition for improving oral inflammation including Xanthium strumarium and extract of Sward bean as an effective ingredient and preparing method thereof |
KR102406286B1 (en) | 2021-12-23 | 2022-06-13 | 국립낙동강생물자원관 | Antibacterial composition using extract of Penthorum chinense |
-
2016
- 2016-03-22 KR KR1020160033805A patent/KR101782858B1/en active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210047451A (en) * | 2019-10-22 | 2021-04-30 | (주)성원화장품 | Composition for improving oral inflammation including Xanthium strumarium and extract of Sward bean as an effective ingredient and preparing method thereof |
KR102364900B1 (en) * | 2019-10-22 | 2022-02-17 | (주)성원화장품 | Composition for improving oral inflammation including Xanthium strumarium and extract of Sward bean as an effective ingredient and preparing method thereof |
CN111000752A (en) * | 2020-01-06 | 2020-04-14 | 陕西润和堂医药有限公司 | Traditional Chinese medicine toothpaste for resisting helicobacter pylori |
KR102406286B1 (en) | 2021-12-23 | 2022-06-13 | 국립낙동강생물자원관 | Antibacterial composition using extract of Penthorum chinense |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8435499B2 (en) | Toothpowder composition containing wheat flour and bamboo salt | |
JP4246736B2 (en) | Composition for oral dental treatment of medicinal herbs and preparation method thereof | |
JP4948044B2 (en) | Plaque formation inhibitor or anti-cariogenic agent | |
KR101782858B1 (en) | Toothpaste composition comprising of medicinal plants | |
KR101046621B1 (en) | Antimicrobial composition comprising sun-dried salt and koji mulberry extract | |
KR102299387B1 (en) | Antimicrobial toothpaste composition | |
KR20200012181A (en) | Toothpaste composition comprising herbal extract mixture as effective component | |
KR101778058B1 (en) | Composition for sanitation promotion of oral cavity comprising natural medicinal ingredient extract as effective component for halitosis inducing microoranism and infectious disease of mucous membrane | |
KR20140031512A (en) | Composition for treating oral disease and inhibiting halitosis comprising the extract of schizandra chinensis | |
KR20060083915A (en) | Oral hygiene composition containing an extract of Sancho and its manufacturing method | |
KR102622954B1 (en) | Toothpaste composition for improving or preventing gingivitis and periodontitis | |
KR101916377B1 (en) | Composition for teeth whitening and preparation method therefor | |
KR20180008120A (en) | The Preparation methods of Mouth wash which containing Herb Extracts and Essential oil | |
KR101632910B1 (en) | Mouth spray composition comprising cypress extracts and medical herb extracts and manufacturing method thereof | |
KR101365352B1 (en) | Composition for treating oral disease and inhibiting halitosis comprising the extract of Alder tree | |
KR102230888B1 (en) | Toothpaste composition | |
KR102283663B1 (en) | Antimicrobial composition comprising extracts of herb | |
JP6631223B2 (en) | Oral antibacterial agent and oral composition | |
KR102308516B1 (en) | Composition for teeth whitening containing enteromorpha extracts | |
CN107737083A (en) | A kind of children's toothpaste and preparation method thereof | |
KR101599767B1 (en) | A toothpaste composition comprising non-toxic mineral sulfur and a method for preparation thereof | |
KR102214621B1 (en) | Functional food composition containing black kelp | |
KR101466769B1 (en) | Composition for treating or preventing oral bacterial infection diseases comprising an extract of artemisia fukudo | |
KR20170142740A (en) | Composition for treating or preventing oral diseases comprising natural complex | |
KR102350693B1 (en) | Tooth brightening composition for teeth whitening and brightness improvement activation containing lotus extracts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20160322 |
|
PA0201 | Request for examination | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20170420 Patent event code: PE09021S01D |
|
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20170730 |
|
N231 | Notification of change of applicant | ||
PN2301 | Change of applicant |
Patent event date: 20170915 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20170922 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20170925 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20200908 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20210906 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20230921 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |